StreetInsider.com News Articles

Form 4 NEPHROS INC For: Aug 18 Filed by: Wexford GP LLC

Thu, 20 Aug 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260820/26956335.html

Form 4 NEPHROS INC For: Aug 18 Filed by: Wexford GP LLC

Thu, 20 Aug 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260820/26956335.html

Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results

Tue, 18 Aug 2026 09:20:34 -0400

Benchmark analyst Robert Wasserman reiterated a Speculative Buy rating and $6.00 price target on Nephros (NASDAQ: NEPH).

The analyst commented, "Nephros reported positive financial results for their 2Q26, including revenues of $6.0 million, up 36% year-overyear, and improved earnings of $0.11 per share versus $0.02 the prior year. Our estimates had been revenues of $5.1 million, a 15% increase from 2Q25, with net income of $0.01. Results in 2Q26 were boosted by higher programmatic (recurring) product sales and service revenue, as well as a $600,000 one-time tariff refund which reduced cost of goods sold. Company management did not provide specific forward

Form 4 NEPHROS INC For: Aug 12 Filed by: Amron Arthur H

Fri, 14 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260814/26930325.html

Form 4 NEPHROS INC For: Aug 12 Filed by: Amron Arthur H

Fri, 14 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260814/26930325.html

Form 10-Q NEPHROS INC For: Jun 30

Mon, 10 Aug 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260810/26897568.html

Form 10-Q NEPHROS INC For: Jun 30

Mon, 10 Aug 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260810/26897568.html

Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026

Thu, 06 Aug 2026 16:10:00 -0400

Record Second-Quarter Net Revenue Growth of 36% to $6 million;
Core Programmatic Revenue Grew by 27% Year Over Year

SOUTH ORANGE, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2026.

Financial Highlights

Net revenue was a record $6 million, compared to $4.4 million in the second quarter of 2025, up 36%
Net income

Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026

Thu, 06 Aug 2026 16:10:00 -0400

Record Second-Quarter Net Revenue Growth of 36% to $6 million;
Core Programmatic Revenue Grew by 27% Year Over Year

Financial Highlights

Net revenue was a record $6 million, compared to $4.4 million in the second quarter of 2025, up 36%
Net income

Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026

Thu, 06 Aug 2026 16:10:00 -0400

Record Second-Quarter Net Revenue Growth of 36% to $6 million;
Core Programmatic Revenue Grew by 27% Year Over Year

Financial Highlights

Net revenue was a record $6 million, compared to $4.4 million in the second quarter of 2025, up 36%
Net income

Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026

Thu, 06 Aug 2026 16:10:00 -0400

Record Second-Quarter Net Revenue Growth of 36% to $6 million;
Core Programmatic Revenue Grew by 27% Year Over Year

Financial Highlights

Net revenue was a record $6 million, compared to $4.4 million in the second quarter of 2025, up 36%
Net income

Form 8-K NEPHROS INC For: Aug 06

Thu, 06 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260806/26883329.html

Form 8-K NEPHROS INC For: Aug 06

Thu, 06 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260806/26883329.html

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

Wed, 05 Aug 2026 16:00:00 -0400

SOUTH ORANGE, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second quarter financial results on Thursday, August 06, 2026 after market close and will host a conference call that same day at 4:30pm ET.

Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

Wed, 05 Aug 2026 16:00:00 -0400

Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

Wed, 05 Aug 2026 16:00:00 -0400

Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

Wed, 05 Aug 2026 16:00:00 -0400

Participants may dial into the call as follows:
Domestic access: 1 (844) 808-7106
International access: 1 (412) 317-5285

Upon joining, please ask to be joined into the Nephros conference call.

Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET